WELGENE

Welgene Biotech Co., Ltd. is a leading provider of instruments, reagents, and services in the life sciences field. The company has launched a number of innovative clinical products, including:
Array comparative genomic hybridization(Cytoscan) is a more sensitive and specific way to detect chromosomal abnormalities than traditional chromosome analysis. It can detect microdeletions and microduplications that are not visible under a microscope.
Exome sequencing(ACMG-59) is a high-throughput sequencing technique that can identify genetic variants in all protein-coding regions of the genome. Exome sequencing is used to diagnose a variety of genetic conditions, including rare diseases, inherited cancers, and developmental disorders.
Non-invasive prenatal testing(Welbaby) is a noninvasive way to screen for chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It is performed by analyzing free fetal DNA in maternal blood.
Welgene's products and services are in line with standards and have obtained a number of certifications, including TAF, TFDA/LDTS etc.. The company is committed to providing customers with high-quality clinical product services.

Werfen Taiwan Limited

Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain.

We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant. Through our Original Equipment Manufacturing (OEM) business line, we research, develop, and manufacture customized assays and biomaterials.

We operate directly in 30 countries, and in more than 100 territories through distributors. Our Headquarters and Technology Centers are located in the US and Europe. Worldwide sales exceed €1.84 billion in 2022, and our workforce is more than 7,000 strong.

Yourgene Health (Taiwan) in partnership with INEX Innovate (Singapore)

With more than 13 years of Next Generation Sequencing (NGS) experiences, Yourgene Health (Taiwan) Co., Ltd offers reliable services including NIPT (Non-Invasive Prenatal Testing), tumor profiling, clinical research services and bioinformatic solutions to customers in APAC region. Yourgene Taipei service laboratory has acquired ISO/IEC 17025:2017 accreditation and Taiwan LDTS listing for NIPT (Non-Invasive Prenatal Testing) services.

Yourgene Health (Taiwan) Co., Ltd works in partnership with global leaders in DNA technology on:
• Leading NIPT solutions for labs and clinicians: Sage™ prenatal screen and the IONA® Nx test
• NGS research services: Spatial transcriptomics, whole genome sequencing, whole exome sequencing and metagenomic sequencing
• Clinical oncology research
• Oncology tertiary analysis: Molecular Health
• Reproductive health

INEX Innovate is a women and fetal health molecular diagnostics company based in Singapore, specializing in reproductive health and gynaecological cancer. Founded since 2006, it’s mission is to provide innovative solutions and services to address unmet clinical needs.

INEX Innovate Products:

• OvaCis® Rapid Test Kit- Intraoperative ovarian cancer detection test that differentiates benign from malignant ovarian cyst by utilizing lateral flow device.
• epiHERA® Early Endometrial Cancer Detection Test- Early endometrial cancer detection test which detects hypermethylated biomarkers from samples collected from ThinPrep swab.